113 related articles for article (PubMed ID: 25026900)
1. Preventive antiretroviral therapy in non-thalassemia carrier infants exposed to mother-to-child transmission of HIV decreases cord and after delivery red blood production without altering the development of hemoglobin.
Pornprasert S; Wongnoi R; Oberdorfer P; Sirivatanapa P
Curr HIV Res; 2014; 12(3):227-31. PubMed ID: 25026900
[TBL] [Abstract][Full Text] [Related]
2. Effects of antiretroviral drugs for prevention of HIV-mother-to-child transmission on hematological parameters and hemoglobin synthesis in HIV-uninfected newborns with and without thalassemia carrier.
Wongnoi R; Oberdorfer P; Sirivatanapa P; Phanpong C; Pornprasert S
Curr HIV Res; 2013 Apr; 11(3):187-92. PubMed ID: 23607655
[TBL] [Abstract][Full Text] [Related]
3. Safety of 6-week Neonatal Triple-combination Antiretroviral Postexposure Prophylaxis in High-risk HIV-exposed Infants.
Anugulruengkitt S; Suntarattiwong P; Ounchanum P; Srirompotong U; Jantarabenjakul W; Sophonphan J; Punnahitanon S; Pancharoen C; Cressey TR; Chokephaibulkit K; Puthanakit T;
Pediatr Infect Dis J; 2019 Oct; 38(10):1045-1050. PubMed ID: 31365477
[TBL] [Abstract][Full Text] [Related]
4. Identifying high or low risk of mother to child transmission of HIV: How Harare City, Zimbabwe is doing?
Komtenza B; Satyanarayana S; Takarinda KC; Mukungunugwa SH; Mugurungi O; Chonzi P; Sithole N; Bvochora T; Mushavi A
PLoS One; 2019; 14(3):e0212848. PubMed ID: 30865646
[TBL] [Abstract][Full Text] [Related]
5. Mother-to-Child Transmission Outcomes of HIV-Exposed Infants Followed Up in Jos North-Central Nigeria.
Sagay AS; Ebonyi AO; Meloni ST; Musa J; Oguche S; Ekwempu CC; Oyebode T; Ejeliogu E; Imade GE; Agbaji OO; Okonkwo P; Kanki PJ
Curr HIV Res; 2015; 13(3):193-200. PubMed ID: 25986370
[TBL] [Abstract][Full Text] [Related]
6. Implementation and Operational Research: Uptake of Services and Behaviors in the Prevention of Mother-to-Child HIV Transmission Cascade in Zimbabwe.
McCoy SI; Buzdugan R; Padian NS; Musarandega R; Engelsmann B; Martz TE; Mushavi A; Mahomva A; Cowan FM
J Acquir Immune Defic Syndr; 2015 Jun; 69(2):e74-81. PubMed ID: 26009838
[TBL] [Abstract][Full Text] [Related]
7. Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: An analysis of the women and infants transmission study.
Pacheco SE; McIntosh K; Lu M; Mofenson LM; Diaz C; Foca M; Frederick M; Handelsman E; Hayani K; Shearer WT;
J Infect Dis; 2006 Oct; 194(8):1089-97. PubMed ID: 16991083
[TBL] [Abstract][Full Text] [Related]
8. Influence of new antiretrovirals on hematological toxicity in HIV-exposed uninfected infants.
Rovira N; Noguera-Julian A; Rives S; Berrueco R; Lahoz R; Fortuny C
Eur J Pediatr; 2016 Jul; 175(7):1013-7. PubMed ID: 27165499
[TBL] [Abstract][Full Text] [Related]
9. Serum lactate levels in infants exposed peripartum to antiretroviral agents to prevent mother-to-child transmission of HIV: Agence Nationale de Recherches Sur le SIDA et les Hépatites Virales 1209 study, Abidjan, Ivory Coast.
Ekouevi DK; Touré R; Becquet R; Viho I; Sakarovitch C; Rouet F; Towne-Gold B; Fassinou P; Leroy V; Blanche S; Dabis F;
Pediatrics; 2006 Oct; 118(4):e1071-7. PubMed ID: 16950945
[TBL] [Abstract][Full Text] [Related]
10. Safety and effectiveness of antiretroviral drugs during pregnancy, delivery and breastfeeding for prevention of mother-to-child transmission of HIV-1: the Kesho Bora Multicentre Collaborative Study rationale, design, and implementation challenges.
Kesho Bora Study Group
Contemp Clin Trials; 2011 Jan; 32(1):74-85. PubMed ID: 20854932
[TBL] [Abstract][Full Text] [Related]
11. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
[TBL] [Abstract][Full Text] [Related]
12. Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants.
Feiterna-Sperling C; Weizsaecker K; Bührer C; Casteleyn S; Loui A; Schmitz T; Wahn V; Obladen M
J Acquir Immune Defic Syndr; 2007 May; 45(1):43-51. PubMed ID: 17356471
[TBL] [Abstract][Full Text] [Related]
13. Elevated frequencies of micronucleated erythrocytes in infants exposed to zidovudine in utero and postpartum to prevent mother-to-child transmission of HIV.
Witt KL; Cunningham CK; Patterson KB; Kissling GE; Dertinger SD; Livingston E; Bishop JB
Environ Mol Mutagen; 2007; 48(3-4):322-9. PubMed ID: 17358032
[TBL] [Abstract][Full Text] [Related]
14. Exposure to antiretroviral agents during pregnancy does not alter bone status in infants.
Mora S; Giacomet V; Viganò A; Cafarelli L; Stucchi S; Pivetti V; Manfredini V; Puzzovio M; Zuccotti G
Bone; 2012 Jan; 50(1):255-8. PubMed ID: 22080170
[TBL] [Abstract][Full Text] [Related]
15. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
16. The effect of maternal HIV status and treatment duration on body composition of HIV-exposed and HIV-unexposed preterm, very and extremely low-birthweight infants.
Strydom K; Nel DG; Dhansay MA; Van Niekerk E
Paediatr Int Child Health; 2018 Aug; 38(3):163-174. PubMed ID: 29790827
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.
Chalermchockcharoenkit A; Culnane M; Chotpitayasunondh T; Vanprapa N; Leelawiwat W; Mock PA; Asavapiriyanont S; Teeraratkul A; McConnell MS; McNicholl JM; Tappero JW
Clin Infect Dis; 2009 Jul; 49(2):299-305. PubMed ID: 19522656
[TBL] [Abstract][Full Text] [Related]
18. Perinatal zidovudine prophylaxis in HIV type-1-infected pregnant women with thalassaemia carriage in Thailand.
Briand N; Pornprasert S; Ngo-Giang-Huong N; Galactéros F; Pissard S; Tatu T; Sanguansermsri T; Jourdain G; Lallemant M; Le Coeur S
Antivir Ther; 2009; 14(1):117-22. PubMed ID: 19320245
[TBL] [Abstract][Full Text] [Related]
19. Hematological alterations and thymic function in newborns of HIV-infected mothers receiving antiretroviral drugs.
Wongnoi R; Penvieng N; Singboottra P; Kingkeow D; Oberdorfer P; Sirivatanapa P; Pornprasert S
Indian Pediatr; 2013 Jun; 50(6):567-72. PubMed ID: 23502663
[TBL] [Abstract][Full Text] [Related]
20. Development of nevirapine resistance in infants is reduced by use of infant-only single-dose nevirapine plus zidovudine postexposure prophylaxis for the prevention of mother-to-child transmission of HIV-1.
Eshleman SH; Hoover DR; Hudelson SE; Chen S; Fiscus SA; Piwowar-Manning E; Jackson JB; Kumwenda NI; Taha TE
J Infect Dis; 2006 Feb; 193(4):479-81. PubMed ID: 16425125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
